argenx

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• argenx completes USD 77.00 acquisition. Forte Biosciences stock leaves Nasdaq (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• argenx SE Stock 12‑Month Price Target Raised to $1206.02, Implies 26% Upside (öffnet in neuem Tab)

  TradingView · 01.10.2026

• argenx presents new VYVGART data for argenx stock (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Argenx Se (ARGX) and Obsidian Therapeutics (OBX) (öffnet in neuem Tab)

  theglobeandmail.com · 30.09.2026

• argenx stock falls 2.06 percent as VYVGART data arrive (öffnet in neuem Tab)

  AD HOC NEWS · 30.09.2026

• (ARGX) Risk Channels and Responsive Allocation (öffnet in neuem Tab)

  Stock Traders Daily · 30.09.2026

• Argenx to present new data across its portfolio, pipeline at 2026 AANEM (öffnet in neuem Tab)

  TipRanks · 29.09.2026

• BofA Securities Maintains Argenx SE(ARGX.US) With Buy Rating (öffnet in neuem Tab)

  Moomoo · 29.09.2026

• Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium (öffnet in neuem Tab)

  BioSpace · 29.09.2026

• Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA (öffnet in neuem Tab)

  TipRanks · 29.09.2026

• Treatment data for nerve and muscle conditions is on argenx (ARGX)’s conference agenda. (öffnet in neuem Tab)

  Stock Titan · 29.09.2026

• Argenx Presents New Vyvgart Data at AANEM and MGFA Congresses (öffnet in neuem Tab)

  Ideal Investisseur · 29.09.2026

• No-Moat Argenx's Growth Led by Vyvgart; Pipeline Brings Long-Term Diversification (öffnet in neuem Tab)

  Morningstar · 28.09.2026

• Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial (öffnet in neuem Tab)

  TipRanks · 28.09.2026

• argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• argenx SE (CEUX:ARGXb) - Valuation Measures & Financial Statistics (öffnet in neuem Tab)

  GuruFocus · 28.09.2026

• argenx stock reports 60 percent Q2 sales growth now (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• argenx stock at EUR 845.20 on September 25, 2026, up 1.25 percent (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months (öffnet in neuem Tab)

  The Motley Fool · 26.09.2026

• Will Board Refresh Change argenx Stock Narrative (öffnet in neuem Tab)

  Simply Wall Street · 26.09.2026

• Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch (öffnet in neuem Tab)

  TipRanks · 25.09.2026

• Argenx stock last at EUR 842.40, up 0.91 percent in Euronext trading (öffnet in neuem Tab)

  AD HOC NEWS · 25.09.2026

• Argenx SE : Goldman Sachs remains its Buy rating (öffnet in neuem Tab)

  marketscreener.com · 25.09.2026

• Argenx shares head into the open after September 24 market data (öffnet in neuem Tab)

  AD HOC NEWS · 25.09.2026

• argenx SE A (1AE.MU) Q2 FY2026 earnings call transcript (öffnet in neuem Tab)

  Yahoo Finance · 25.09.2026

• Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today (öffnet in neuem Tab)

  Benzinga · 24.09.2026

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading (öffnet in neuem Tab)

  MT Newswires · 24.09.2026

• Can argenx (ENXTBR:ARGX) Justify Its Price As New Board Appointments Shift Focus? (öffnet in neuem Tab)

  Simply Wall Street · 24.09.2026

• argenx (ENXTBR:ARGX) Shares Moved, So What Is Drawing Attention Now? (öffnet in neuem Tab)

  Simply Wall St. · 24.09.2026

• Argenx stock heads into the open after a 0.39 percent drop (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026